Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications.

Head & neck·2026
Same author

Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG).

Cancer treatment reviews·2026
Same author

A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumors.

Future oncology (London, England)·2025
Same author

Primary Synovial Sarcoma of the Abdomen and Pelvis.

American journal of clinical oncology·2025
Same author

An adaptive transformer-based framework for advanced brain activity mapping and intelligent neurotherapeutic decision support.

Frontiers in human neuroscience·2025
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.4K

Chemotherapy for soft-tissue sarcomas.

Vinod Ravi, Shreyaskumar Patel, Robert S Benjamin

    Oncology (Williston Park, N.Y.)
    |January 17, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Metastatic soft-tissue sarcomas are treated with cytotoxic chemotherapy, including doxorubicin or gemcitabine combinations. A personalized treatment plan considering patient goals and disease characteristics is crucial for effective sarcoma management.

    More Related Videos

    Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
    08:04

    Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

    Published on: March 18, 2014

    13.4K
    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

    Published on: July 28, 2020

    10.5K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    15.4K
    Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
    08:04

    Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

    Published on: March 18, 2014

    13.4K
    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

    Published on: July 28, 2020

    10.5K

    Area of Science:

    • Medical Oncology
    • Clinical Pharmacology
    • Sarcoma Research

    Background:

    • Cytotoxic chemotherapy remains the primary treatment for metastatic soft-tissue sarcomas.
    • Standard regimens include doxorubicin with ifosfamide or dacarbazine, and gemcitabine with docetaxel.

    Purpose of the Study:

    • To outline a goal-oriented approach for formulating effective treatment plans for soft-tissue sarcomas.
    • To emphasize the importance of considering histology, performance status, disease sites, and patient goals in treatment selection.

    Main Methods:

    • Review of current standard chemotherapy regimens for metastatic soft-tissue sarcomas.
    • Discussion of the strategic selection of single-agent and combination chemotherapy.
    • Consideration of systemic therapy in localized soft-tissue sarcoma with high recurrence risk.

    Main Results:

    • Doxorubicin and gemcitabine-based combinations are mainstays for metastatic disease.
    • A tailored approach considering individual patient and disease factors is vital.
    • Neoadjuvant therapy efficacy can guide treatment decisions and optimize outcomes.

    Conclusions:

    • Effective soft-tissue sarcoma treatment requires a personalized, goal-oriented strategy.
    • Careful selection of chemotherapy regimens is essential for managing metastatic and localized disease.
    • Neoadjuvant treatment evaluation can improve toxicity profiles and recurrence-free survival.